Home » Azbil BioVigilant to Distribute BioTrends Software
Azbil BioVigilant to Distribute BioTrends Software
Azbil BioVigilant has entered into an agreement with Archilex to distribute in North America the BioTrends product line--a paperless data-management solution for pharmaceutical laboratory and manufacturing environments.
Developed in close collaboration with the pharmaceutical industry, BioTrends software streamlines management of quality assurance environmental monitoring (EM) processes and the monitoring and trending of all EM data points including water, air, surface, gas, personnel, raw materials and finished products, the company says. With this easy-to-use, paperless tool, pharmaceutical companies can improve the quality and reduce the costs for all areas of their microbiological laboratory.
According to a University of Pisa study, implementation of the BioTrends solution demonstrated a time savings of 58 percent for microbiological EM activities compared to traditional paper-process methods.
The package is 21 CFR Part 11 compliant and can simplify operators’ data entry tasks while providing managers with a powerful tool for data analysis, trending and report generation. The software also can be used to schedule and manage all routine EM activities. The Windows-based software is offered in both stand-alone and enterprise editions, with separate modules to enable activity scheduling and automated barcode data collection. A range of validation and maintenance support options is also offered. For more information, visit www.biovigilant.com .
Merck Stops Development of Parkinsonís DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesnít work
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »